Increased Levels of Soluble P-Selectin in Hypercholesterolemic Patients
- 17 March 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (10) , 953-957
Abstract
Background —Hypercholesterolemia is considered a major risk factor for the development of atherosclerosis. Enhanced lipid peroxidation and persistent platelet activation can be observed in vivo in hypercholesterolemic patients and may have pathophysiological implications in the occurrence of cardiovascular events. P-selectin may play an important role in the pathogenesis of multicellular events, including atherosclerosis. We studied the impact of hypercholesterolemia and oxidative stress on plasma levels of P-selectin. Methods and Results —Plasma levels of P-selectin were measured by means of an enzyme immunoassay in 20 hypercholesterolemic patients with no clinical evidence of cardiovascular disease and in 20 sex- and age-matched normocholesterolemic subjects. Hypercholesterolemic patients had higher levels of P-selectin compared with that of control subjects (98±61 versus 56±14 ng/mL; P =.001). They also displayed increased von Willebrand Factor (vWF) levels (176±22 versus 119±12%; P =.0001). A direct correlation was observed between P-selectin and LDL cholesterol levels (ρ=.453). Administration of vitamin E (600 mg/d for 2 weeks) to hypercholesterolemic patients significantly reduced plasma P-selectin (40%), and an inverse correlation was observed between vitamin E and P-selectin plasma levels (ρ=−.446). Conclusions —Hypercholesterolemia is associated with elevated plasmatic P-selectin. Altered oxidative processes leading to endothelial dysfunction and persistent platelet activation may contribute to increased soluble P-selectin levels. P-selectin may be proposed as a marker of endothelial dysfunction in hypercholesterolemic patients.Keywords
This publication has 35 references indexed in Scilit:
- In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Local Amplification of Platelet Function by 8-Epi Prostaglandin F2α Is Not Mediated by Thromboxane Receptor IsoformsJournal of Biological Chemistry, 1996
- Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndromeBritish Journal of Haematology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.Journal of Clinical Investigation, 1992
- Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.Journal of Clinical Investigation, 1992
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytesCell, 1989
- A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation.Journal of Cell Biology, 1985
- LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in AtherosclerosisAnnual Review of Biochemistry, 1983